BriaCell Therapeutics (NASDAQ:BCTXW) Stock Quotes, Forecast and News Summary

Q: How do I buy BriaCell Therapeutics (BCTXW) stock?

You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTXW) through any online brokerage. View our list of the best stock brokerages

Q: Who are BriaCell Therapeutics (BCTXW) competitors?

Other companies in BriaCell Therapeutics’s space includes: Sarepta Therapeutics (NASDAQ:SRPT) , Exact Sciences (NASDAQ:EXAS) , Neurocrine Biosciences (NASDAQ:NBIX) , Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN) .

Q: What is the forecast, or price target, for BriaCell Therapeutics (BCTXW) stock?

There is no analysis for BriaCell Therapeutics to provide a consensus price target.

Q: What is the current price for BriaCell Therapeutics (BCTXW)?

The stock price for BriaCell Therapeutics (NASDAQ: BCTXW) is $0.3282 last updated December 18, 2024 at 7:38 AM EST.

Q: Does BriaCell Therapeutics (BCTXW) pay a dividend?

There are no upcoming dividends for BriaCell Therapeutics.

Q: When is BriaCell Therapeutics (NASDAQ:BCTXW) reporting earnings?

BriaCell Therapeutics does not have any upcoming earnings scheduled.

Q: Is BriaCell Therapeutics (BCTXW) going to split?

There is no upcoming split for BriaCell Therapeutics.

Q: What sector and industry does BriaCell Therapeutics (BCTXW) operate in?

BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BriaCell Therapeutics Stock (NASDAQ: BCTXW) stock price, news, charts, stock research, profile.

Open	$0.31
Close	$0.28
Volume / Avg.	32.49K / 159.25K
Day Range	$0.23 - $0.31
52 Wk Range	0.11 - 2.60
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	-
Days to Cover	1

Recent News

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.31
Close	$0.28
Volume / Avg.	32.49K / 159.25K
Day Range	$0.23 - $0.31
52 Wk Range	0.11 - 2.60
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BriaCell Therapeutics (BCTXW) stock?

You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTXW) through any online brokerage.

View our list of the best stock brokerages

Who are BriaCell Therapeutics (BCTXW) competitors?

Other companies in BriaCell Therapeutics’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for BriaCell Therapeutics (BCTXW) stock?

There is no analysis for BriaCell Therapeutics to provide a consensus price target.

What is the current price for BriaCell Therapeutics (BCTXW)?

The stock price for BriaCell Therapeutics (NASDAQ: BCTXW) is $0.3282 last updated December 18, 2024 at 7:38 AM EST.

Does BriaCell Therapeutics (BCTXW) pay a dividend?

There are no upcoming dividends for BriaCell Therapeutics.

When is BriaCell Therapeutics (NASDAQ:BCTXW) reporting earnings?

BriaCell Therapeutics does not have any upcoming earnings scheduled.

Is BriaCell Therapeutics (BCTXW) going to split?

There is no upcoming split for BriaCell Therapeutics.

What sector and industry does BriaCell Therapeutics (BCTXW) operate in?

BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

BriaCell Therapeutics

BriaCell Therapeutics (BCTXW) Forecast